Nationwide Announces Fund Closures
Nationwide recommended the liquidation and closure of the Funds following consideration of the Funds' long-term growth prospects, among other factors.
The Funds' last day of trading will be
About Nationwide
Nationwide, a Fortune 100 company based in
For more information, visit www.nationwide.com.
Subscribe today to receive the latest news from Nationwide and follow Nationwide PR on X.
Call 1-800-617-0004 to request a summary prospectus and/or a prospectus or download prospectuses at etf.nationwidefinancial.com. These prospectuses outline investment objectives, risks, fees, charges and expenses, and other information that you should read and consider carefully before investing.
Investing involves risk, including the possible loss of principal. Shares of any ETF are bought and sold at market price (not NAV), may trade at a discount or premium to NAV, and are not individually redeemed from the Fund. Brokerage commissions will reduce returns.
Nationwide Fund Advisors (NFA) is the registered investment advisor to Nationwide ETFs, which are distributed by Quasar Distributors LLC. NFA is not affiliated with any distributor, subadviser, or index provider contracted by NFA for the Nationwide ETFs. Representatives of the Nationwide ETF Sales Desk are registered with Nationwide Investment Services Corporation, member FINRA,
Nationwide, Nationwide is on your side and the Nationwide N and Eagle are service marks of Nationwide Mutual Insurance Company. © 2024
MFM-5424AO
NFA-482433-2024-01-16
Contact:
(740) 974-1918
[email protected]
View original content to download multimedia:https://www.prnewswire.com/news-releases/nationwide-announces-fund-closures-302039496.html
SOURCE Nationwide
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- World Fire Congress 2026 concludes with global call for prevention, collaboration and shared resilience
- In HelloNation, Bad Faith Attorney Expert Demián I. Oksenendler Explains Insurance Bad Faith in California
- Renova Pharmaceuticals Announces First Three U.S. Generic Product Launches, Marking a Major Company Milestone
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share